000			03540nam a2200397 i 4500
999			_c393084 _d393084 _x1
001			393084
003			ES-MaUEC
005			20240314174318.0
006			a|||| o|||| 00| 0
007			cr nn 008mamaa
008			100301s1992 xxu| o |||| 0|eng d
020			_a9781592596270
024	7		_a10.1385/0896032116 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC346 _b1992 EB
245	0	0	_aAnimal Models of Neurological Disease _nII, _pMetabolic Encephalopathies and Epilepsies _cedited by Alan A. Boulton, Glen B. Baker, Roger F. Butterworth
250			_a1st edition 1992
264		1	_aTotowa, NJ _bHumana Press _c1992
300			_a1 recurso en línea (XVIII, 373 páginas)
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aNeuromethods _x1940-6045 _v22
505	0		_aExperimental Models of Human Stroke -- Animal Models of Brain Hypoxia -- Animal Models of the Wernicke-Korsakoff Syndrome -- Chemically Induced Models of Seizures -- The Kindling Model of Epilepsy -- Genetically Based Animal Models of Seizures -- Animal Models of Hepatic Encephalopathies -- Animal Models for Reye's Syndrome -- Animal Models of Niacin-Nicotinamide Deficiency -- Pyridoxine Deficiency -- Animal Models of Hereditary Hyperammonemias.
520			_ato the Animal Models Volumes This and several other volumes in the Neuromethods series will describe a number of animal models of neuropsychiatric disorders. Because of increasing public concern over the ethical treatment of animals in research, we felt it incumbent upon us to include this general preface to these volumes in order to indicate why we think further - search using animals is necessary and why animal models of psychiatric disorders, in particular, are so important. We recognize that animals should only be used when suitable alternatives are not available. We think it self-e- dent, however, that humans can only be experimented upon in severely proscribed circumstances and alternative pro- dures using cell or tissue culture are inadequate in any models requiring assessments of behavioral change or of complex in vivo processes. However, when the distress, discomfort, or pain to the animals outweighs the anticipated gains for human welfare, then the research is not ethical and should not be carried out. It is imperative that each individual researcher examine his/her own research from a critical moral standpoint - fore engaging in it, taking into consideration the animals' welfare as well as the anticipated gains. Furthermore, once a decision to proceed with research is made, it is the researcher's responsibility to ensure that the animals' w- fare is of prime concern in terms of appropriate housing, feeding, and maximum reduction of any uncomfortable or distressing effects of the experimental conditions, and that these conditions undergo frequent formalized monitoring.
988			_aSpringer_Protocols_1992
650		7	_2embne _9169088 _aSistema nervioso _xEnfermedades
776	0	8	_iPrinted edition: _z9781489943897
776	0	8	_iPrinted edition: _z9780896032118
776	0	8	_iPrinted edition: _z9781489943880
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/0896032116 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b01/2024 _dz _eb _zSI